TRIM24 mediates the interaction of the retinoic acid receptor alpha with the proteasome

Marilyn Carrier1, Regis Lutzing1, Samia Gaouar1

  • 1Department of Functional Genomics and Cancer, IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), INSERM, U964, CNRS, UMR7104, Université de Strasbourg, Illkirch Cedex, France.

FEBS Letters
|March 16, 2018
PubMed

Insights

The tripartite motif protein TRIM24 links retinoic acid receptor alpha (RARα) to the proteasome for degradation, a process crucial for regulating gene transcription.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Protein Degradation

Background:

  • Nuclear retinoic acid receptors (RARs) regulate gene transcription upon ligand binding.
  • Activated RARs interact with coregulators and are subsequently degraded by the ubiquitin-proteasome system.

Discussion:

  • This study reveals TRIM24's novel role in RARα degradation.
  • TRIM24 acts as an adapter, connecting RARα to the proteasome for ubiquitination and degradation.
  • TRIM24 and the proteasome are recruited to target gene promoters with RARα.

Key Insights:

  • TRIM24 is essential for the ubiquitination and proteasomal degradation of RARα.
  • TRIM24 functions as a bridge between RARα and the degradation machinery.
  • The degradation process is intrinsically linked to RARα's transcriptional activity at target gene promoters.

Outlook:

  • Further investigation into TRIM24's role in other RAR subtypes and nuclear receptors.
  • Exploring the therapeutic potential of modulating TRIM24-mediated degradation for diseases involving RARα dysregulation.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
111.4K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
8.1K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.3K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.7K
The Proteasome02:18

The Proteasome

4.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K